全球靜脈輸液市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計靜脈輸液市場將從 2025 年的 198.1 億美元成長到 2034 年的 409.1 億美元，2026 年至 2034 年的複合年成長率為 8.39%。

靜脈輸液市場正穩定成長，主要受住院率上升、慢性病管理以及需要腸外輸液的手術數量增加的推動。生理食鹽水、葡萄糖和平衡電解質溶液在急診醫學、外科手術和重症監護中的廣泛應用支撐了穩定的需求。已開發市場人口老化和新興經濟體醫院基礎設施的持續改善是推動市場成長的主要因素，而標準化靜脈輸液療法的普及則改善了臨床療效，並擴大了市場規模。

關鍵成長要素包括外科手術量的增加、脫水和敗血症發病率的上升，以及在某些臨床情況下，平衡結晶溶液比傳統生理食鹽水更受青睞。日益嚴格的監管和品管要求促使製造商轉向符合GMP規範的生產，以滿足嚴格的無菌和包裝標準。面對間歇性供不應求，供應鏈韌性已成為一項關鍵挑戰，促使製造商投資於冗餘產能、區域填充和包裝基地，並改善特殊靜脈製劑的低溫運輸物流。

未來前景包括預混合料和客製化靜脈輸液袋的成長、拓展門診輸液服務以及配方創新（針對特定患者群體量身定做的電解質平衡解決方案）。配備生物感測器的輸液幫浦和互聯輸液管理系統有望為製造商創造更多服務機會。能夠保證供應穩定性、展現成本效益高的生產能力並透過臨床數據支持醫院藥品清單的新興參與企業，將在全球醫療系統對可靠、高品質注射劑的需求不斷成長的背景下，擴大市場佔有率。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球靜脈輸液市場：依類型分類

• 市場分析、洞察與預測
• 全靜脈營養
• 周邊靜脈營養

第5章：全球靜脈輸液市場：依成分分類

• 市場分析、洞察與預測
• 碳水化合物
• 維生素和礦物質
• 單劑量胺基酸製劑
• 腸外脂肪乳劑
• 其他作品

第6章：全球靜脈輸液市場：依年齡層別分類

• 市場分析、洞察與預測
• 兒童
• 成人
• 老年人

第7章 全球靜脈輸液市場：依應用分類

• 市場分析、洞察與預測
• 營養支持
• 輸血
• 體液和電解質平衡
• 其他用途

第8章：全球靜脈輸液市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 門診手術中心
• 居家醫療環境

第9章 全球靜脈輸液市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AdvaCare Pharma
  • Amanta Healthcare
  • Axa Parenterals
  • B. Braun
  • Baxter International
  • Fresenius Kabi
  • Grifols
  • ICU Medical
  • JW Life Science
  • Otsuka Pharmaceutical

The Intravenous Solutions Market size is expected to reach USD 40.91 Billion in 2034 from USD 19.81 Billion (2025) growing at a CAGR of 8.39% during 2026-2034.

The intravenous (IV) solutions market has shown steady expansion driven by rising hospital admissions, chronic disease management, and increased procedural volumes requiring parenteral fluids. Broad use of saline, dextrose, and balanced electrolyte solutions across emergency care, surgery, and critical care underpins consistent demand. Growth is supported by aging populations in developed markets and expanding hospital infrastructure in emerging economies, where access to standardized IV therapies is improving clinical outcomes and supporting market scale-up.

Key drivers comprise increasing surgical procedures, rising incidence of dehydration and sepsis, and a growing preference for balanced crystalloids over traditional saline in certain clinical settings. Regulatory scrutiny and quality-control requirements push manufacturers toward GMP-compliant production with stringent sterility and packaging standards. Supply-chain resilience has become a core concern following episodic shortages; consequently, manufacturers invest in redundant capacity, regional fill-and-finish sites, and improved cold-chain logistics for specialty parenteral formulations.

Future prospects include growth in premixed and customized IV bags, expansion into ambulatory infusion services, and formulation innovations (electrolyte-balanced solutions tailored to specific patient populations). Biosensor-enabled IV pumps and connected infusion management may create adjunct service opportunities for manufacturers. Market entrants who can guarantee supply security, demonstrate cost-effective manufacturing, and support hospital formularies through clinical data will capture incremental share as healthcare systems globally push for reliable, high-quality parenteral therapy supplies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

By Composition

• Carbohydrates
• Vitamins And Minerals
• Single-Dose Amino Acids
• Parenteral Lipid Emulsion
• Other Compositions

By Age Group

• Pediatric
• Adults
• Geriatric

By Application

• Nutritional Support
• Blood Transfusion
• Fluid And Electrolyte Balance
• Other Applications

By End Use

• Hospitals And Clinics
• Ambulatory Surgery Centers
• Home Care Settings

COMPANIES PROFILED

• AdvaCare Pharma, Amanta Healthcare, Axa Parenterals, B Braun, Baxter International, Fresenius Kabi, Grifols, ICU Medical, JW Life Science, Otsuka Pharmaceutical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Total Parenteral Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Peripheral Parenteral Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY COMPOSITION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Composition
• 5.2. Carbohydrates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Vitamins And Minerals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Single-Dose Amino Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Parenteral Lipid Emulsion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Compositions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age Group
• 6.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Geriatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Nutritional Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Blood Transfusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Fluid And Electrolyte Balance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Composition
  • 9.2.3 By Age Group
  • 9.2.4 By Application
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Composition
  • 9.3.3 By Age Group
  • 9.3.4 By Application
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Composition
  • 9.4.3 By Age Group
  • 9.4.4 By Application
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Composition
  • 9.5.3 By Age Group
  • 9.5.4 By Application
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Composition
  • 9.6.3 By Age Group
  • 9.6.4 By Application
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INTRAVENOUS SOLUTIONS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 AdvaCare Pharma
  • 11.2.2 Amanta Healthcare
  • 11.2.3 Axa Parenterals
  • 11.2.4 B. Braun
  • 11.2.5 Baxter International
  • 11.2.6 Fresenius Kabi
  • 11.2.7 Grifols
  • 11.2.8 ICU Medical
  • 11.2.9 JW Life Science
  • 11.2.10 Otsuka Pharmaceutical